Massive pericardial effusion in scleroderma: A review of five cases

M. Satoh, M. Tokuhira, N. Hama, Michito Hirakata, M. Kuwana, M. Akizuki, Y. Ichikawa, S. Ogawa, M. Homma

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Medical records of five patients with sclerodenna (SSc), each of whom had pericardial effusion with an estimated volume of more than 200 ml, were reviewed to study the clinical and immunological significance of massive pericardial effusion in SSc. Diffuse SSc (4/5), with a wide area of pigmentation (4/5), flexion contracture (4/5), oesophageal hypomotility (5/5), pulmonary fibrosis (4/5) and autoantibodies to topoisomerase I (3/5) were the common features in this group. High protein, lactate dehydrogenase and low white blood cell count were the characteristics of pericardial fluid. None of the patients had signs of acute pericarditis. Four of the five cases died within 9 months of the diagnosis of pericarditis; two with renal failure, one with cardiac tamponade and another with sudden death. The pericarditis in diffuse SSc, especially in cases with anti-topoisomerase I, may be characterized by a chronic form of pericarditis with poor prognosis, often complicated by ,renal failure.

Original languageEnglish
Pages (from-to)564-567
Number of pages4
JournalRheumatology
Volume34
Issue number6
DOIs
Publication statusPublished - 1995 Jun

Fingerprint

Scleroderma
Pericarditis
Pericardial Effusion
Blood
blood cell count
Autoantibodies
Cells
Sudden Death
Proteins
Fibrosis
fibrosis
leukocytes
Type I DNA Topoisomerase
lactates
dehydrogenases
Fluids
prognosis
Prognosis
death
Acute

Keywords

  • Antinuclear antibodies
  • Antitopoisomerase I antibodies
  • Pericardial effusion
  • Renal failure
  • Scleroderma

ASJC Scopus subject areas

  • Molecular Biology
  • Statistics and Probability
  • Computational Mathematics
  • Condensed Matter Physics
  • Applied Mathematics
  • Pharmacology (medical)
  • Rheumatology
  • Neuroscience(all)

Cite this

Satoh, M., Tokuhira, M., Hama, N., Hirakata, M., Kuwana, M., Akizuki, M., ... Homma, M. (1995). Massive pericardial effusion in scleroderma: A review of five cases. Rheumatology, 34(6), 564-567. https://doi.org/10.1093/rheumatology/34.6.564

Massive pericardial effusion in scleroderma : A review of five cases. / Satoh, M.; Tokuhira, M.; Hama, N.; Hirakata, Michito; Kuwana, M.; Akizuki, M.; Ichikawa, Y.; Ogawa, S.; Homma, M.

In: Rheumatology, Vol. 34, No. 6, 06.1995, p. 564-567.

Research output: Contribution to journalArticle

Satoh, M, Tokuhira, M, Hama, N, Hirakata, M, Kuwana, M, Akizuki, M, Ichikawa, Y, Ogawa, S & Homma, M 1995, 'Massive pericardial effusion in scleroderma: A review of five cases', Rheumatology, vol. 34, no. 6, pp. 564-567. https://doi.org/10.1093/rheumatology/34.6.564
Satoh, M. ; Tokuhira, M. ; Hama, N. ; Hirakata, Michito ; Kuwana, M. ; Akizuki, M. ; Ichikawa, Y. ; Ogawa, S. ; Homma, M. / Massive pericardial effusion in scleroderma : A review of five cases. In: Rheumatology. 1995 ; Vol. 34, No. 6. pp. 564-567.
@article{0ba6a5e596c74a1080566f4fa4d3e571,
title = "Massive pericardial effusion in scleroderma: A review of five cases",
abstract = "Medical records of five patients with sclerodenna (SSc), each of whom had pericardial effusion with an estimated volume of more than 200 ml, were reviewed to study the clinical and immunological significance of massive pericardial effusion in SSc. Diffuse SSc (4/5), with a wide area of pigmentation (4/5), flexion contracture (4/5), oesophageal hypomotility (5/5), pulmonary fibrosis (4/5) and autoantibodies to topoisomerase I (3/5) were the common features in this group. High protein, lactate dehydrogenase and low white blood cell count were the characteristics of pericardial fluid. None of the patients had signs of acute pericarditis. Four of the five cases died within 9 months of the diagnosis of pericarditis; two with renal failure, one with cardiac tamponade and another with sudden death. The pericarditis in diffuse SSc, especially in cases with anti-topoisomerase I, may be characterized by a chronic form of pericarditis with poor prognosis, often complicated by ,renal failure.",
keywords = "Antinuclear antibodies, Antitopoisomerase I antibodies, Pericardial effusion, Renal failure, Scleroderma",
author = "M. Satoh and M. Tokuhira and N. Hama and Michito Hirakata and M. Kuwana and M. Akizuki and Y. Ichikawa and S. Ogawa and M. Homma",
year = "1995",
month = "6",
doi = "10.1093/rheumatology/34.6.564",
language = "English",
volume = "34",
pages = "564--567",
journal = "Rheumatology (United Kingdom)",
issn = "1462-0324",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Massive pericardial effusion in scleroderma

T2 - A review of five cases

AU - Satoh, M.

AU - Tokuhira, M.

AU - Hama, N.

AU - Hirakata, Michito

AU - Kuwana, M.

AU - Akizuki, M.

AU - Ichikawa, Y.

AU - Ogawa, S.

AU - Homma, M.

PY - 1995/6

Y1 - 1995/6

N2 - Medical records of five patients with sclerodenna (SSc), each of whom had pericardial effusion with an estimated volume of more than 200 ml, were reviewed to study the clinical and immunological significance of massive pericardial effusion in SSc. Diffuse SSc (4/5), with a wide area of pigmentation (4/5), flexion contracture (4/5), oesophageal hypomotility (5/5), pulmonary fibrosis (4/5) and autoantibodies to topoisomerase I (3/5) were the common features in this group. High protein, lactate dehydrogenase and low white blood cell count were the characteristics of pericardial fluid. None of the patients had signs of acute pericarditis. Four of the five cases died within 9 months of the diagnosis of pericarditis; two with renal failure, one with cardiac tamponade and another with sudden death. The pericarditis in diffuse SSc, especially in cases with anti-topoisomerase I, may be characterized by a chronic form of pericarditis with poor prognosis, often complicated by ,renal failure.

AB - Medical records of five patients with sclerodenna (SSc), each of whom had pericardial effusion with an estimated volume of more than 200 ml, were reviewed to study the clinical and immunological significance of massive pericardial effusion in SSc. Diffuse SSc (4/5), with a wide area of pigmentation (4/5), flexion contracture (4/5), oesophageal hypomotility (5/5), pulmonary fibrosis (4/5) and autoantibodies to topoisomerase I (3/5) were the common features in this group. High protein, lactate dehydrogenase and low white blood cell count were the characteristics of pericardial fluid. None of the patients had signs of acute pericarditis. Four of the five cases died within 9 months of the diagnosis of pericarditis; two with renal failure, one with cardiac tamponade and another with sudden death. The pericarditis in diffuse SSc, especially in cases with anti-topoisomerase I, may be characterized by a chronic form of pericarditis with poor prognosis, often complicated by ,renal failure.

KW - Antinuclear antibodies

KW - Antitopoisomerase I antibodies

KW - Pericardial effusion

KW - Renal failure

KW - Scleroderma

UR - http://www.scopus.com/inward/record.url?scp=0029160760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029160760&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/34.6.564

DO - 10.1093/rheumatology/34.6.564

M3 - Article

C2 - 7633799

AN - SCOPUS:0029160760

VL - 34

SP - 564

EP - 567

JO - Rheumatology (United Kingdom)

JF - Rheumatology (United Kingdom)

SN - 1462-0324

IS - 6

ER -